Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMET: Metformin in Huntington's Disease
NCT04826692Phase 3Completed
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Apr 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in Huntington's disease (HD), sponsored by Health Research Institute Hospital La Fe. Started Apr 2022; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT04826692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04826692.